MRI in the prognostic evaluation of patients with rectal cancer

Affiliations

¹ Department of Gastrointestinal Surgery, Peking University Shougang Hospital, Beijing, China.
² Department of Radiology, Peking University Shougang Hospital, Beijing, China.
³ Department of Oncology, Peking University Shougang Hospital, Beijing, China.
⁴ Department of Oncology, Peking University Shougang Hospital, Beijing, China; Gastrointestinal Cancer Center, Peking University Cancer Hospital, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing 100142, China; Peking-Tsinghua Center for Life Science, Peking University International Cancer Center, Beijing, China. Electronic address: zlgujin@126.com.

Comment

Qingkun Gao et al. Lancet Oncol. 2022 Aug.

. 2022 Aug;23(8):e366.

doi: 10.1016/S1470-2045(22)00393-X.

¹ Department of Gastrointestinal Surgery, Peking University Shougang Hospital, Beijing, China.
² Department of Radiology, Peking University Shougang Hospital, Beijing, China.
³ Department of Oncology, Peking University Shougang Hospital, Beijing, China.
⁴ Department of Oncology, Peking University Shougang Hospital, Beijing, China; Gastrointestinal Cancer Center, Peking University Cancer Hospital, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing 100142, China; Peking-Tsinghua Center for Life Science, Peking University International Cancer Center, Beijing, China. Electronic address: zlgujin@126.com.

No abstract available

Conflict of interest statement

We declare no competing interests.

MRI in the prognostic evaluation of patients with rectal cancer - Authors' reply.
Brown G; study authors. Brown G, et al. Lancet Oncol. 2022 Aug;23(8):e367. doi: 10.1016/S1470-2045(22)00453-3. Lancet Oncol. 2022. PMID: 35901828 No abstract available.

Assessment of the 2020 NICE criteria for preoperative radiotherapy in patients with rectal cancer treated by surgery alone in comparison with proven MRI prognostic factors: a retrospective cohort study.
Lord AC, Corr A, Chandramohan A, Hodges N, Pring E, Airo-Farulla C, Moran B, Jenkins JT, Di Fabio F, Brown G. Lord AC, et al. Lancet Oncol. 2022 Jun;23(6):793-801. doi: 10.1016/S1470-2045(22)00214-5. Epub 2022 May 2. Lancet Oncol. 2022. PMID: 35512720